Related Experiment Video
Updated: Jun 14, 2026

Visualizing Clathrin-mediated Endocytosis of G Protein-coupled Receptors at Single-event Resolution via TIRF Microscopy
Published on: October 20, 2014
A new inhibitor of the β-arrestin/AP2 endocytic complex reveals interplay between GPCR internalization and signalling
Alexandre Beautrait1, Justine S Paradis2, Brandon Zimmerman3
1Department of Biochemistry, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Quebec, Canada H3T 1J4.
Abstract:
In addition to G protein-coupled receptor (GPCR) desensitization and endocytosis, β-arrestin recruitment to ligand-stimulated GPCRs promotes non-canonical signalling cascades. Distinguishing the respective contributions of β-arrestin recruitment to the receptor and β-arrestin-promoted endocytosis in propagating receptor signalling has been limited by the lack of selective analytical tools. Here, using a combination of virtual screening and cell-based assays, we have identified a small molecule that selectively inhibits the interaction between β-arrestin and the β2-adaptin subunit of the clathrin adaptor protein AP2 without interfering with the formation of receptor/β-arrestin complexes. This selective β-arrestin/β2-adaptin inhibitor (Barbadin) blocks agonist-promoted endocytosis of the prototypical β2-adrenergic (β2AR), V2-vasopressin (V2R) and angiotensin-II type-1 (AT1R) receptors, but does not affect β-arrestin-independent (transferrin) or AP2-independent (endothelin-A) receptor internalization. Interestingly, Barbadin fully blocks V2R-stimulated ERK1/2 activation and blunts cAMP accumulation promoted by both V2R and β2AR, supporting the concept of β-arrestin/AP2-dependent signalling for both G protein-dependent and -independent pathways.
Insights
Researchers developed Barbadin, a novel small molecule that selectively inhibits β-arrestin/AP2 interaction. This tool helps distinguish β-arrestin roles in G protein-coupled receptor signaling and endocytosis.
Area of Science:
- Pharmacology
- Cell Biology
- Molecular Signaling
Background:
- G protein-coupled receptors (GPCRs) undergo desensitization and endocytosis.
- β-arrestin recruitment to GPCRs triggers non-canonical signaling cascades.
- Selective tools are needed to differentiate β-arrestin's roles in receptor signaling and endocytosis.
Purpose of the Study:
- To identify a small molecule that selectively inhibits the β-arrestin/AP2 interaction.
- To investigate the role of β-arrestin/AP2 interaction in GPCR signaling and endocytosis.
Main Methods:
- Virtual screening and cell-based assays were employed.
- A selective β-arrestin/β2-adaptin inhibitor, Barbadin, was identified.
- Barbadin's effects on receptor internalization and signaling pathways were assessed.
Main Results:
- Barbadin selectively inhibits the β-arrestin/β2-adaptin interaction without affecting receptor/β-arrestin complex formation.
- Barbadin blocks agonist-promoted endocytosis of β2AR, V2R, and AT1R.
- Barbadin inhibits V2R-stimulated ERK1/2 activation and blunts cAMP accumulation for V2R and β2AR.
Conclusions:
- Barbadin is a valuable tool for dissecting β-arrestin-mediated signaling.
- β-arrestin/AP2 interaction is crucial for endocytosis of various GPCRs.
- β-arrestin/AP2-dependent signaling pathways contribute to both G protein-dependent and -independent signaling.
Related Concept Videos
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
GPCR Desensitization
G-Protein Gated Ion Channels
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity
Two...
IP3/DAG Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...

